Anti LP40 antibody, subclass IgG4 LA294

( DrugBank: - / KEGG DRUG: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	8

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	15

13. Multiple sclerosis/Neuromyelitis optica

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

trials per page:

Showing 1 to 8 of 8 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-007459-28-BG (EUCTR)	30/04/2010	29/04/2010	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Relapsing-Remitting Multiple Sclerosis MedDRA version: 14.0;Level: PT;Classification code 10063399;T ...	Product Name: LY2127399 Product Code: LY2127399 INN or Proposed INN: N/a Other descriptive name: Anti L ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	245		France;Czech Republic;Hungary;Finland;Belgium;Denmark;Bulgaria;Germany
2	EUCTR2008-007459-28-DE (EUCTR)	08/10/2009	23/12/2008	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Relapsing-Remitting Multiple Sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10063399;T ...	Product Name: LY2127399 Product Code: LY2127399 INN or Proposed INN: N/a Other descriptive name: Anti L ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	245		France;Czech Republic;Hungary;Finland;Belgium;Denmark;Bulgaria;Germany
3	EUCTR2008-007459-28-BE (EUCTR)	21/09/2009	07/01/2009	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Relapsing-Remitting Multiple Sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10063399;T ...	Product Name: LY2127399 Product Code: LY2127399 INN or Proposed INN: N/a Other descriptive name: Anti L ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	500		France;Czech Republic;Hungary;Finland;Belgium;Denmark;Bulgaria;Germany
4	EUCTR2008-007459-28-CZ (EUCTR)	22/07/2009	05/05/2009	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Relapsing-Remitting Multiple Sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10063399;T ...	Product Name: LY2127399 Product Code: LY2127399 INN or Proposed INN: N/a Other descriptive name: Anti L ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	245		Hungary;Finland;Germany;Czech Republic;Denmark;Belgium;Bulgaria;France
5	EUCTR2008-007459-28-DK (EUCTR)	09/07/2009	29/05/2009	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Relapsing-Remitting Multiple Sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10063399;T ...	Product Name: LY2127399 Product Code: LY2127399 INN or Proposed INN: N/a Other descriptive name: Anti L ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	245		France;Czech Republic;Hungary;Finland;Belgium;Denmark;Bulgaria;Germany
6	EUCTR2008-007459-28-FR (EUCTR)	01/07/2009	15/05/2009	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Relapsing-Remitting Multiple Sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10063399;T ...	Product Name: LY2127399 Product Code: LY2127399 INN or Proposed INN: N/a Other descriptive name: Anti L ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	500	Phase 2	France;Czech Republic;Hungary;Finland;Belgium;Denmark;Bulgaria;Germany
7	EUCTR2008-007459-28-HU (EUCTR)	01/07/2009	27/04/2009	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Relapsing-Remitting Multiple Sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10063399;T ...	Product Name: LY2127399 Product Code: LY2127399 INN or Proposed INN: N/a Other descriptive name: Anti L ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	500		Finland;Hungary;Czech Republic;Germany;Denmark;Belgium;Bulgaria;France
8	EUCTR2008-007459-28-FI (EUCTR)	25/06/2009	18/03/2009	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Re ...	Relapsing-Remitting Multiple Sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10063399;T ...	Product Name: LY2127399 Product Code: LY2127399 INN or Proposed INN: N/a Other descriptive name: Anti L ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	245		France;Czech Republic;Hungary;Finland;Belgium;Denmark;Bulgaria;Germany

First Previous1Next Last

46. Malignant rheumatoid arthritis

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

trials per page:

Showing 1 to 10 of 15 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-004894-16-HU (EUCTR)	03/12/2009	17/11/2008	Phase 2, Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody ...	Phase 2, Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody ...	Rheumatoid arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: LY2127399 Other descriptive name: Anti LP40 antibody, subclass IgG4 LA294	Eli Lilly and Company limited	NULL	Not Recruiting	Female: yes Male: yes	150	Phase 2	Czech Republic;Hungary;Poland;Germany
2	EUCTR2008-004875-23-HU (EUCTR)	08/07/2009	11/05/2009	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	Rheumatoid arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: LY2127399 Other descriptive name: Anti LP40 antibody, subclass IgG4 LA294	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	198		Hungary;Germany;Belgium;France;Austria;Poland
3	EUCTR2008-004875-23-AT (EUCTR)	26/06/2009	30/04/2009	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	Rheumatoid arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: LY2127399 Product Code: NA Other descriptive name: Anti LP40 antibody, subclass IgG4 LA2 ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	236		Hungary;Germany;Belgium;France;Poland;Austria
4	EUCTR2008-001105-42-PL (EUCTR)	03/06/2009	17/04/2009	A Phase 2 Study of Multiple Intravenous Doses of LY2127399, an Anti-BAFF Human Antibody, in Patients ...	A Phase 2 Study of Multiple Intravenous Doses of LY2127399, an Anti-BAFF Human Antibody, in Patients ...	Rheumatoid arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Code: LY2127399 INN or Proposed INN: N/A Other descriptive name: Anti LP40 antibody, subclass ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	100	Phase 2	Germany;Belgium;France;Austria;Poland
5	EUCTR2008-004875-23-DE (EUCTR)	26/05/2009	09/03/2009	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	Rheumatoid arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: LY2127399 Product Code: NA Other descriptive name: Anti LP40 antibody, subclass IgG4 LA2 ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	236		Hungary;Germany;Belgium;France;Austria;Poland
6	EUCTR2008-004875-23-BE (EUCTR)	18/05/2009	07/01/2009	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	Rheumatoid arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: LY2127399 Other descriptive name: Anti LP40 antibody, subclass IgG4 LA294	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	236		France;Hungary;Poland;Belgium;Austria;Germany
7	EUCTR2008-004875-23-PL (EUCTR)	22/04/2009	25/02/2009	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	Rheumatoid arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: LY2127399 Product Code: NA Other descriptive name: Anti LP40 antibody, subclass IgG4 LA2 ...	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	236		Hungary;Germany;Belgium;France;Austria;Poland
8	EUCTR2008-004894-16-CZ (EUCTR)	14/04/2009	26/11/2008	Phase 2, Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody ...	Phase 2, Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody ...	Rheumatoid arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: LY2127399 Other descriptive name: Anti LP40 antibody, subclass IgG4 LA294	Eli Lilly and Company limited	NULL	Not Recruiting	Female: yes Male: yes	150	Phase 2	Hungary;Germany;Czech Republic;Poland
9	EUCTR2008-004875-23-FR (EUCTR)	31/03/2009	16/04/2009	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibo ...	Rheumatoid arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: LY2127399 Other descriptive name: Anti LP40 antibody, subclass IgG4 LA294	Eli Lilly and Company	NULL	Not Recruiting	Female: yes Male: yes	236	Phase 2	France;Hungary;Poland;Belgium;Austria;Germany
10	EUCTR2008-004894-16-DE (EUCTR)	12/02/2009	11/11/2008	Phase 2, Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody ...	Phase 2, Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody ...	Rheumatoid arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: LY2127399 Other descriptive name: Anti LP40 antibody, subclass IgG4 LA294	Eli Lilly and Company limited	NULL	Not Recruiting	Female: yes Male: yes	150	Phase 2	Hungary;Czech Republic;Germany;Poland

First Previous1 2Next Last